Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 31876 - 31900 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cisplatin	Approved Investigational	NODAL	4838	upregulated	Cisplatin results in increased expression of NODAL mRNA	10q22.1	A22206
Cisplatin	Approved Investigational	NPRL2	10641	downregulated	Cisplatin results in decreased expression of NPRL2 mRNA	3p21.31	A20660
Cisplatin	Approved Investigational	NQO1	1728	downregulated	Cisplatin results in decreased expression of NQO1 mRNA	16q22.1	A20427
Cisplatin	Approved Investigational	NR3C1	2908	downregulated	Cisplatin results in decreased expression of NR3C1 mRNA	5q31.3	A20427
Cisplatin	Approved Investigational	NR4A1	3164	upregulated	Cisplatin results in increased expression of NR4A1 mRNA	12q13.13	A22203
Cisplatin	Approved Investigational	NSMCE2	286053	upregulated	Cisplatin results in increased expression of NSMCE2 mRNA	8q24.13	A22204
Cisplatin	Approved Investigational	NT5C2	22978	upregulated	Cisplatin results in increased expression of NT5C2 mRNA	10q24.32-q24.33	A20660
Cisplatin	Approved Investigational	NTPCR	84284	upregulated	Cisplatin results in increased expression of NTPCR mRNA	1q42.2	A20427
Cisplatin	Approved Investigational	NUAK1	9891	downregulated	Cisplatin results in decreased expression of NUAK1 mRNA	12q23.3	A20427
Cisplatin	Approved Investigational	NUMB	8650	downregulated	Cisplatin results in decreased expression of NUMB mRNA	14q24.3	A22204
Cisplatin	Approved Investigational	NXF1	10482	upregulated	Cisplatin results in increased expression of NXF1 mRNA	11q12.3	A22204
Cisplatin	Approved Investigational	OGFOD1	55239	downregulated	Cisplatin results in decreased expression of OGFOD1 mRNA	16q13	A22204
Cisplatin	Approved Investigational	ORAI3	93129	downregulated	Cisplatin results in decreased expression of ORAI3 mRNA	16p11.2	A21499
Cisplatin	Approved Investigational	OSBPL10	114884	downregulated	Cisplatin results in decreased expression of OSBPL10 mRNA	3p23	A22204
Cisplatin	Approved Investigational	OSGIN1	29948	downregulated	Cisplatin results in decreased expression of OSGIN1 mRNA	16q23.3	A20427
Cisplatin	Approved Investigational	OSGIN1	29948	upregulated	Cisplatin results in increased expression of OSGIN1 mRNA	16q23.3	A22204
Cisplatin	Approved Investigational	OSR2	116039	upregulated	Cisplatin results in increased expression of OSR2 mRNA	8q22.2	A22204
Cisplatin	Approved Investigational	OXSM	54995	upregulated	Cisplatin results in increased expression of OXSM mRNA	3p24.2	A20427
Cisplatin	Approved Investigational	P4HA1	5033	downregulated	Cisplatin results in decreased expression of P4HA1 mRNA	10q22.1	A20427
Cisplatin	Approved Investigational	PAIP1	10605	downregulated	Cisplatin results in decreased expression of PAIP1 mRNA	5p12	A20660
Cisplatin	Approved Investigational	PALB2	79728	downregulated	Cisplatin results in decreased expression of PALB2 mRNA	16p12.2	A21499
Cisplatin	Approved Investigational	PANK1	53354	downregulated	Cisplatin results in decreased expression of PANK1 mRNA	10q23.31	A20427
Cisplatin	Approved Investigational	PAPPA	5069	downregulated	Cisplatin results in decreased expression of PAPPA mRNA	9q33.1	A22204
Cisplatin	Approved Investigational	PARD3	56288	downregulated	Cisplatin results in decreased expression of PARD3 mRNA	10p11.22-p11.21	A20660
Cisplatin	Approved Investigational	PARN	5073	downregulated	Cisplatin results in decreased expression of PARN mRNA	16p13.12	A22204

Displaying entries 31876 - 31900 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability